title: Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
authors: Zsuzsanna
authors: Z
authors: Kurgyis
authors: Rita
authors: R
authors: Varga
authors: Isabell
authors: I
authors: Sick
authors: Martin Ulrich
authors: MU
authors: Lang
authors: Thomas
authors: T
authors: Ruzicka
authors: Miklós
authors: M
authors: Sárdy
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D005260:Female; D006229:Hand Dermatoses / Q000188:drug therapy; D006801:Humans; D007642:Keratosis / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D011928:Raynaud Disease / Q000150:complications; D012595:Scleroderma, Systemic / Q000150:complications*; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan